Delivery Order SPE2DB22D2206-SPE2DB25FEZ91
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,598,453 units of Candesartan Cilexetil 32 mg tablets in 90-count bottles. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,504.01, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, worth $999,999,999. The IDC serves...
This federal contract award is for the delivery of Candesartan Cilexetil 8 mg tablets in 90-count packages. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Candesartan Cilexetil 16 mg tablets in 90-count bottles. The contract, valued at $5,474.47, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a completion date of December 11, 2024 and is a firm-fixed-price delivery order. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,824.15 delivery order contract is for the provision of Candesartan Cilexetil 32 mg tablets. The contract has a firm fixed price pricing type and runs through November 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Candesartan Cilexetil 16 mg tablets, with a ceiling value of $3,683.69. The award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range...
This federal contract award is for the delivery of candesartan cilexetil 16 mg tablets in 90-count bottles, with a total ceiling value of $10,448.05. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) on November 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 13, 2024. This award is not designated as...
This federal contract award is for the delivery of Candesartan Cilexetil 8 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $1,614.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on October 30, 2024, with a completion date of October 31, 2024. The contract is not designated as a set-aside.
AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This contract award is for the delivery of 4,566,299,651 units of the pharmaceutical drug Candesartan Cilexetil 32 mg tablets, in 90-tablet bottles. The contract, valued at $8,755.92, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA).
The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,089.38 firm fixed-price delivery order is for the supply of 90-count bottles of 32mg Candesartan Cilexetil tablets. The contract has an ultimate completion date of October 10, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Candesartan Cilexetil 16 mg tablets in 90-count packages. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The total contract ceiling value is $4,404.34, and the award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The contract does not...